Neil Smith active positions
| Companies | Position | Start | End |
|---|---|---|---|
Modulate Therapeutics, Inc.
 Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Director/Board Member | 31/12/2014 | - |
Censa Pharmaceuticals, Inc.
 Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Chief Operating Officer | 30/09/2016 | - |
| Chief Tech/Sci/R&D Officer | 30/09/2016 | - |
Career history of Neil Smith
Statistics
International
| Canada | 2 |
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Modulate Therapeutics, Inc.
Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Health Technology |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Health Technology |
- Stock Market
- Insiders
- Neil Smith
- Experience
